Target Information

Target General Infomation
Target ID
T20401
Former ID
TTDS00306
Target Name
Carbonic anhydrase II
Gene Name
CA2
Synonyms
CA-II; Carbonate dehydratase II; Carbonic anhydrase C; CA2
Target Type
Successful
Disease Arthritis [ICD9: 710-719; ICD10: M00-M25]
Breast cancer [ICD9: 174, 175; ICD10: C50]
Cancer [ICD9: 140-229; ICD10: C00-C96]
Duodenal ulcers [ICD10: K25-K27]
Edema associated with congestive heart failure [ICD9: 428.0, 782.3; ICD10: I50, R60.9]
High blood pressure; Edema [ICD9:401; ICD10: I10-I16, R60.9]
Insomnia [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52; ICD10: F51.0, G47.0]
Open-angle glaucoma [ICD9: 365; ICD10: H40-H42]
Function
Essential for bone resorption and osteoclast differentiation (By similarity). Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6.
BioChemical Class
Carbon-oxygen lyases
Target Validation
T20401
UniProt ID
P00918
EC Number
EC 4.2.1.1
Sequence
MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRIL
NNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHL
VHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDP
RGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM
VDNWRPAQPLKNRQIKASFK
Drugs and Mode of Action
Drug(s) Benzthiazide Drug Info Approved High blood pressure; Edema [1], [2], [3]
Chlorothiazide Drug Info Approved Edema associated with congestive heart failure [4], [5], [3]
Cyclothiazide Drug Info Approved Edema associated with congestive heart failure [6], [7], [3]
Dorzolamide Drug Info Approved Open-angle glaucoma [8], [9]
Ethinamate Drug Info Approved Insomnia [10], [11]
MAFENIDE Drug Info Approved Bacterial infection [12]
SALICYLATE Drug Info Phase 4 Discovery agent [13]
CG-100649 Drug Info Phase 3 Arthritis [14], [15]
Curcumin Drug Info Phase 3 Cancer [16], [17]
GUAIACOL Drug Info Phase 3 Discovery agent [18]
PARABEN Drug Info Phase 3 Discovery agent [19]
SULTHIAME Drug Info Phase 3 Discovery agent [20]
PHENOL Drug Info Phase 2/3 Discovery agent [21]
COUMATE Drug Info Phase 2 Breast cancer [22]
BUTYLATEDHYDROXYTOLUENE Drug Info Phase 1 Discovery agent [23]
SULFAMIDE Drug Info Phase 1 Discovery agent [24]
6-ethoxy-1,3-benzothiazole-2-sulfonamide Drug Info Withdrawn from market Duodenal ulcers [25]
Inhibitor (2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate Drug Info [26]
(2-bromophenyl)difluoromethanesulfonamide Drug Info [27]
(4-bromophenyl)difluoromethanesulfonamide Drug Info [27]
1,2,4-Triazole Drug Info [28]
1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide Drug Info [29]
1,4-phenylene disulfamate Drug Info [30]
1-(3,4-dichlorophenyl)-3-hydroxyurea Drug Info [31]
1-acetamido-5-sulfonamidoindane Drug Info [32]
1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide Drug Info [29]
1-cyclohexylamido-5-sulfonamidoindane Drug Info [32]
1-pentafluorophenylamido-5-sulfonamidoindane Drug Info [32]
1-pentenyl-4-(aminosulfonyl)benzoate Drug Info [33]
1-valproylamido-5-sulfonamidoindane Drug Info [32]
2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide Drug Info [34]
2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide Drug Info [34]
2,3-dihydro-1H-indene-5-sulfonamide Drug Info [35]
2,4-dichloro-5-sulfamoylbenzoic acid Drug Info [36]
2,4-Disulfamyltrifluoromethylaniline Drug Info [37]
2,6-di-t-butylphenol Drug Info [38]
2,6-di-tert-butyl-4-methoxyphenol Drug Info [38]
2,6-Difluorobenzenesulfonamide Drug Info [39]
2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide Drug Info [40]
2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide Drug Info [40]
2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide Drug Info [40]
2-(4-hydroxybenzylideneamino)ethanesulfonamide Drug Info [41]
2-(4-tert-butylbenzylideneamino)ethanesulfonamide Drug Info [41]
2-(benzylideneamino)ethanesulfonamide Drug Info [41]
2-(benzyloxyamino)-N-hydroxyhexanamide Drug Info [40]
2-(N''-Acetyl-hydrazino)-benzenesulfonamide Drug Info [42]
2-acetamido-5-sulfonamidoindane Drug Info [32]
2-Acetylamino-indan-5-sulfonic acid hydrate Drug Info [35]
2-Amino-benzenesulfonamide Drug Info [37]
2-Amino-indan-5-sulfonic acid Drug Info [35]
2-butylamido-5-sulfonamidoindane Drug Info [32]
2-cyclohexylamido-5-sulfonamidoindane Drug Info [32]
2-ethylamido-5-sulfonamidoindane Drug Info [32]
2-Hydrazinocarbonyl-benzenesulfonamide Drug Info [42]
2-hydrazinylbenzenesulfonamide Drug Info [43]
2-Hydroxycinnamic acid Drug Info [44]
2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide Drug Info [45]
2-methoxyestradiol 3,17-O,O-bis-sulfamate Drug Info [46]
2-methoxyestradiol-17-O-sulfamate Drug Info [46]
2-methoxyestrrone-3-O-sulfamate Drug Info [46]
2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide Drug Info [47]
2-nonylamido-5-sulfonamidoindane Drug Info [32]
2-oxo-2H-thiochromene-3-carboxylic acid Drug Info [48]
2-pentafluorophenylamido-5-sulfonamidoindane Drug Info [32]
2-propylamido-5-sulfonamidoindane Drug Info [32]
2-Sulfamoyl-benzoic acid methyl ester Drug Info [42]
2-valproylamido-5-sulfonamidoindane Drug Info [32]
3,5-Difluorobenzenesulfonamide Drug Info [28]
3-((4-aminophenyl)diazenyl)benzenesulfonamide Drug Info [49]
3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide Drug Info [49]
3-(3-Phenyl-ureido)-benzenesulfonamide Drug Info [34]
3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide Drug Info [49]
3-(4-sulfamoylphenyl)propanoic acid Drug Info [37]
3-Amino-benzenesulfonamide Drug Info [50]
3-bromophenyl-difluoromethanesulfonamide Drug Info [27]
3-Chloro-4-hydrazino-benzenesulfonamide Drug Info [42]
3-Fluoro-4-hydrazino-benzenesulfonamide Drug Info [42]
3-hydroxy-2-methoxybenzaldehyde Drug Info [38]
3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide Drug Info [51]
3-Mercuri-4-Aminobenzenesulfonamide Drug Info [28]
3-Nitro-benzenesulfonamide Drug Info [52]
3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide Drug Info [53]
3-phenylprop-1-enylboronic acid Drug Info [54]
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID Drug Info [55]
4,4'-thiodipyridine-3-sulfonamide Drug Info [56]
4,5-DICHLOROBENZENE-1,3-DISULFONAMIDE Drug Info [55]
4,6-Dinitro salicylic acid Drug Info [57]
4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide Drug Info [49]
4-((benzylideneamino)methyl)benzenesulfonamide Drug Info [41]
4-(2-Amino-ethyl)-benzenesulfonamide Drug Info [58]
4-(2-AMINOETHYL)BENZENESULFONAMIDE Drug Info [55]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide Drug Info [37]
4-(2-Hydroxy-ethyl)-benzenesulfonamide Drug Info [59]
4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide Drug Info [56]
4-(2-Phenylacetamido)-3-bromobenzenesulfonamide Drug Info [60]
4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide Drug Info [60]
4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide Drug Info [60]
4-(2-Phenylacetamido)benzenesulfonamide Drug Info [60]
4-(2-Phenylacetamidoethyl)benzenesulfonamide Drug Info [60]
4-(2-Phenylacetamidomethyl)benzenesulfonamide Drug Info [60]
4-(2-Propynylthio)pyridine-3-sulfonamide Drug Info [56]
4-(2-Pyridin-2-ylacetamido)benzenesulfonamide Drug Info [60]
4-(2-Pyridin-4-ylacetamido)benzenesulfonamide Drug Info [60]
4-(4-Cyanophenoxy)-3-pyridinesulfonamide Drug Info [56]
4-(4-Fluorophenoxy)-3-pyridinesulfonamide Drug Info [56]
4-(4-hydroxy-benzylideneamino)-benzenesulfonamide Drug Info [41]
4-(4-hydroxybenzylideneamino)benzoic acid Drug Info [41]
4-(4-tert-butylbenzylideneamino)benzoic acid Drug Info [41]
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide Drug Info [56]
4-(Allylamino)-3-pyridinesulfonamide Drug Info [56]
4-(benzylideneamino)benzenesulfonamide Drug Info [41]
4-(benzylideneamino)benzoic acid Drug Info [41]
4-(Carbamolymethylthio)pyridine-3-sulfonamide Drug Info [56]
4-(Cyanomethylthio)pyridine-3-sulfonamide Drug Info [56]
4-(Hydroxymercury)Benzoic Acid Drug Info [28]
4-(hydroxymethyl)benzenesulfonamide Drug Info [37]
4-(Methylhydrazino)-3-pyridinesulfonamide Drug Info [56]
4-(N-Methyl-hydrazino)-benzenesulfonamide Drug Info [61]
4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide Drug Info [56]
4-(Quinolinoxy)-3-pyridinesulfonamide Drug Info [56]
4-Amino-3-bromo-benzenesulfonamide Drug Info [37]
4-Amino-3-chloro-benzenesulfonamide Drug Info [37]
4-Amino-3-fluoro-benzenesulfonamide Drug Info [59]
4-Amino-3-iodo-benzenesulfonamide Drug Info [37]
4-amino-6-chlorobenzene-1,3-disulfonamide Drug Info [59]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info [37]
4-azidobenzenesulfonamide Drug Info [62]
4-Benzenesulfonylamino-benzenesulfonamide Drug Info [34]
4-Benzythiopyridine-3-sulfonamide Drug Info [56]
4-bromophenylboronic acid Drug Info [54]
4-butylphenylboronic acid Drug Info [54]
4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide Drug Info [35]
4-CYANOPHENOL Drug Info [63]
4-Ethoxy-3-pyridinesulfonamide Drug Info [56]
4-ethynyl benzene sulfonamide Drug Info [64]
4-Flourobenzenesulfonamide Drug Info [28]
4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info [30]
4-Hydrazino-3-pyridinesulfonamide Drug Info [56]
4-Hydrazino-benzenesulfonamide Drug Info [65]
4-Hydrazinocarbonyl-benzenesulfonamide Drug Info [42]
4-isothiocyanatobenzenesulfonamide Drug Info [66]
4-Methanesulfonylamino-benzenesulfonamide Drug Info [34]
4-Methoxy-3-pyridinesulfonamide Drug Info [56]
4-methoxyphenylboronic acid Drug Info [54]
4-methoxyphenylsulfamide Drug Info [26]
4-methyl-2-oxo-2H-chromen-7-yl sulfamate Drug Info [27]
4-Methylamino-benzenesulfonamide Drug Info [61]
4-Methylimidazole Drug Info [39]
4-methylphenyl-difluoromethanesulfonamide Drug Info [27]
4-Methylthiopyridine-3-sulfonamide Drug Info [56]
4-Nitro-benzenesulfonamide Drug Info [52]
4-nitrophenyl phosphate Drug Info [67]
4-nitrophenyl-difluoromethanesulfonamide Drug Info [27]
4-nitrophenylsulfamide Drug Info [26]
4-phenoxyphenylboronic acid Drug Info [54]
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide Drug Info [28]
4-Thiocyanato-benzenesulfonamide Drug Info [52]
4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide Drug Info [60]
4-[2-(2-Thienyl)acetamido]benzenesulfonamide Drug Info [60]
4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide Drug Info [34]
5-amino-1,3,4-thiadiazole-2-sulfonamide Drug Info [68]
5-Amino-[1,3,4]thiadiazole-2-thiol Drug Info [69]
5-Chlorosalicylic Acid Drug Info [57]
5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one Drug Info [70]
6-(aminomethyl)-2H-chromen-2-one Drug Info [48]
6-(hydroxymethyl)-2H-chromen-2-one Drug Info [48]
6-Amino-benzothiazole-2-sulfonic acid amide Drug Info [71]
6-ethoxy-1,3-benzothiazole-2-sulfonamide Drug Info [55]
6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE Drug Info [55]
6-Hydroxy-benzothiazole-2-sulfonic acid amide Drug Info [65]
6-hydroxybenzo[d][1,3]oxathiol-2-one Drug Info [72]
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid Drug Info [48]
6-methyl-2-oxo-2H-chromene-3-carboxylic acid Drug Info [48]
6-Nitro-benzothiazole-2-sulfonic acid amide Drug Info [52]
Acetate Ion Drug Info [28]
ACETYLSULFANILAMIDE Drug Info [34]
AL4623 Drug Info [28]
AL5300 Drug Info [28]
AL5424 Drug Info [28]
AL5927 Drug Info [28]
AL6528 Drug Info [28]
Al7089a Drug Info [28]
AL7099A Drug Info [39]
AL7182 Drug Info [28]
Allyl 4-(aminosulfonyl)benzoate Drug Info [33]
Aminobenzolamide derivative Drug Info [73]
Azide Drug Info [74]
BENZOLAMIDE Drug Info [37]
Benzothiazole-2-sulfonic acid amide Drug Info [75]
Benzthiazide Drug Info [76], [77]
Beta-Mercaptoethanol Drug Info [28]
Beta-naphthylboronic acid Drug Info [54]
Biphenyl-4-ylboronic acid Drug Info [54]
BUTYLATEDHYDROXYTOLUENE Drug Info [38]
Carzenide Drug Info [33]
CATECHIN Drug Info [44]
CATECHOL Drug Info [78]
CG-100649 Drug Info [79]
Chlorothiazide Drug Info [80]
COUMARIN Drug Info [81]
COUMATE Drug Info [82]
Curcumin Drug Info [44]
Cyclothiazide Drug Info [83]
Dansylamide Drug Info [28]
Decane-1,10-diyl disulfamate Drug Info [84]
Decyl sulfamate Drug Info [84]
Di(2,6-di-t-butylphenol) Drug Info [38]
Di(2,6-diisopropylphenol) Drug Info [38]
Di(2,6-dimethylphenol) Drug Info [38]
Dorzolamide Drug Info [43]
ELLAGIC ACID Drug Info [78]
EMATE Drug Info [85]
Ethinamate Drug Info [86]
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE Drug Info [55]
FERULIC ACID Drug Info [78]
Formic Acid Drug Info [28]
GALLICACID Drug Info [78]
GUAIACOL Drug Info [38]
HYDROSULFIDE Drug Info [74]
Indane-5-sulfonamide Drug Info [55]
IODIDE Drug Info [74]
MAFENIDE Drug Info [12]
Mercuribenzoic Acid Drug Info [28]
Methyl 4-(4-hydroxybenzylideneamino)benzoate Drug Info [41]
Methyl 4-(4-tert-butylbenzylideneamino)benzoate Drug Info [41]
Methyl Mercury Ion Drug Info [28]
Methyl-phosphonic acid Drug Info [87]
MMI270 Drug Info [40]
N-(1-benzofuran-3-ylmethyl)sulfamide Drug Info [88]
N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE Drug Info [55]
N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide Drug Info [28]
N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide Drug Info [28]
N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide Drug Info [28]
N-(4-cyanophenyl)sulfamide Drug Info [89]
N-(4-Sulfamoyl-phenyl)-benzamide Drug Info [34]
N-(4-Sulfamoyl-phenyl)-butyramide Drug Info [34]
N-(4-Sulfamoyl-phenyl)-isobutyramide Drug Info [34]
N-(4-Sulfamoyl-phenyl)-propionamide Drug Info [34]
N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide Drug Info [90]
N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info [91]
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide Drug Info [69]
N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info [91]
N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info [91]
N-(pentafluorophenyl)sulfamide Drug Info [89]
N-1,3,4-thiadiazol-2-ylsulfamide Drug Info [91]
N-Benzyl-4-Sulfamoyl-Benzamide Drug Info [28]
N-hydroxysulfamide Drug Info [92]
N-hydroxysulfonamides Drug Info [93]
N-propynyl amidebenzenesulphonide Drug Info [94]
N-unsubstituted carbamate esters Drug Info [86]
N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide Drug Info [88]
N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide Drug Info [88]
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide Drug Info [28]
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE Drug Info [55]
N-[4-(trifluoromethyl)phenyl]sulfamide Drug Info [89]
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info [91]
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info [91]
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE Drug Info [55]
NITRATE Drug Info [74]
NSC-654077 Drug Info [45]
Octane-1,8-diyl disulfamate Drug Info [84]
Octyl sulfamate Drug Info [84]
P-Coumaric Acid Drug Info [78]
P-TOLUENESULFONAMIDE Drug Info [37]
P-tolylboronic acid Drug Info [54]
PARABEN Drug Info [78]
PARAOXON Drug Info [67]
Pentane-1,5-diamine Drug Info [95]
Pentanoic acid (4-sulfamoyl-phenyl)-amide Drug Info [34]
Phenethylboronic acid Drug Info [54]
PHENOL Drug Info [44]
Phenoxyarsonous acid Drug Info [74]
Phenyl Boronic acid Drug Info [74]
Phenyl-phosphonic acid Drug Info [87]
PHENYLDIFLUOROMETHANESULFONAMIDE Drug Info [27]
PHENYLMETHANESULFONAMIDE Drug Info [27]
PHENYLSULFAMATE Drug Info [26]
PHENYLSULFAMIDE Drug Info [26]
PRONTOCIL Drug Info [49]
Prop-2-ynyl 4-sulfamoylbenzoate Drug Info [94]
Quinoline-8-sulfonamide Drug Info [30]
RESORCINOL Drug Info [63]
SACCHARIN Drug Info [59]
SALICYLATE Drug Info [63]
Sodium 2,3,5,6-tetrafluorobenzoate Drug Info [96]
SODIUM PERFLUOROHEXANESULFONAMIDE Drug Info [97]
Sodium trithiocarbonate Drug Info [98]
SPARFOSIC ACID Drug Info [87]
SULFAMATE Drug Info [74]
Sulfamic acid 12-sulfamoyloxy-dodecyl ester Drug Info [99]
Sulfamic acid 16-sulfamoyloxy-hexadecyl ester Drug Info [99]
Sulfamic acid 3-sulfamoyloxy-phenyl ester Drug Info [99]
Sulfamic acid 4-sulfamoyloxy-butyl ester Drug Info [99]
Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester Drug Info [99]
Sulfamic acid 6-sulfamoyloxy-hexyl ester Drug Info [99]
Sulfamic acid 7-sulfamoyloxy-heptyl ester Drug Info [99]
Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester Drug Info [100]
Sulfamic acid chroman-2-ylmethyl ester Drug Info [100]
SULFAMIDE Drug Info [74]
Sulfanilamide derivative Drug Info [101]
Sulfenamido-sulfonamides Drug Info [102]
SULTHIAME Drug Info [55]
Syringic Acid Drug Info [78]
Thioureido sulfonamide Drug Info [103]
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM)
TEP EXP Info
Pathways
KEGG Pathway Nitrogen metabolism
Proximal tubule bicarbonate reclamation
Collecting duct acid secretion
Gastric acid secretion
Pancreatic secretion
Bile secretion
NetPath Pathway IL4 Signaling Pathway
EGFR1 Signaling Pathway
Reactome Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Reversible hydration of carbon dioxide
WikiPathways Reversible Hydration of Carbon Dioxide
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
References
REF 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083206.
REF 2(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7125).
REF 3Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
REF 4(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4835).
REF 5FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 084026.
REF 6(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4167).
REF 7FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 013157.
REF 8Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20.
REF 9(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6810).
REF 10FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009750.
REF 11(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7325).
REF 12J Med Chem. 2010 Apr 8;53(7):2913-26.Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
REF 13ClinicalTrials.gov (NCT01712295) 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts. U.S. National Institutes of Health.
REF 14ClinicalTrials.gov (NCT01765296) Phase III Study of CG100649 in Osteoarthritis Patients. U.S. National Institutes of Health.
REF 15(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8316).
REF 16Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst. 2013;30(4):331-68.
REF 17(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7000).
REF 18ClinicalTrials.gov (NCT01119534) Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin. U.S. NationalInstitutes of Health.
REF 19ClinicalTrials.gov (NCT01688479) Trial Comparing Calendula Officinalis With Aqueous Cream "Essex" to Treat Skin Reactions From Radiotherapy of Breast Cancer. U.S. National Institutes of Health.
REF 20ClinicalTrials.gov (NCT00471744) HEAD-Study Optimizing the Treatment of Children With BECTS. U.S. National Institutes of Health.
REF 21ClinicalTrials.gov (NCT02527187) Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa.
REF 22Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer. Expert Rev Anticancer Ther. 2011 Feb;11(2):179-83.
REF 23ClinicalTrials.gov (NCT02221375) Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat Soft MistTM Inhaler B in Healthy Male Volunteers. U.S. National Institutes of Health.
REF 24ClinicalTrials.gov (NCT02216669) Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer. U.S. National Institutes of Health.
REF 25The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54.
REF 26J Med Chem. 2006 Jun 15;49(12):3496-500.Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
REF 27Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6. Epub 2005 Oct 3.Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
REF 28How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
REF 29Eur J Med Chem. 2010 Sep;45(9):3656-61. Epub 2010 May 12.Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
REF 30Bioorg Med Chem. 2009 Jan 15;17(2):553-7. Epub 2008 Dec 6.Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors.
REF 31Bioorg Med Chem Lett. 2006 Aug 15;16(16):4316-20. Epub 2006 Jun 12.N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors.
REF 32J Med Chem. 2006 May 4;49(9):2743-9.Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
REF 33Bioorg Med Chem Lett. 2005 Dec 15;15(24):5429-33. Epub 2005 Oct 6.Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II.
REF 34Bioorg Med Chem Lett. 2005 Nov 1;15(21):4862-6.Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
REF 35Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6.Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
REF 36Bioorg Med Chem. 2010 Jan 15;18(2):930-8. Epub 2009 Nov 20.Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex.
REF 37Bioorg Med Chem Lett. 2009 Dec 1;19(23):6649-54. Epub 2009 Oct 7.Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
REF 38Bioorg Med Chem. 2009 Apr 15;17(8):3207-11. Epub 2009 Feb 4.Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.
REF 39DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-4. Nucleic Acids Res. 2011 January
REF 40Bioorg Med Chem. 2007 Mar 15;15(6):2298-311. Epub 2007 Jan 19.Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I andII with sulfonylated hydroxamates.
REF 41Bioorg Med Chem Lett. 2009 Nov 1;19(21):6014-7. Epub 2009 Sep 17.Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
REF 42J Med Chem. 2005 Mar 24;48(6):2121-5.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporatinghydrazino moieties.
REF 43Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bioorg Med Chem. 2009 Jul 15;17(14):5054-8. Epub 2009 May 30.
REF 44Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3. Epub 2010 Jul 13.Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
REF 45J Med Chem. 2008 Jun 12;51(11):3051-6. Epub 2008 Mar 19.Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.
REF 46J Med Chem. 2008 Mar 13;51(5):1295-308. Epub 2008 Feb 9.Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
REF 47Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72.Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
REF 48J Med Chem. 2010 Jan 14;53(1):335-44.Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.
REF 49Bioorg Med Chem Lett. 2009 Sep 1;19(17):4929-32. Epub 2009 Jul 22.Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
REF 50Bioorg Med Chem Lett. 2005 Feb 15;15(4):1149-54.Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
REF 51J Med Chem. 2006 Sep 7;49(18):5544-51.Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX.
REF 52Bioorg Med Chem Lett. 2004 Nov 15;14(22):5703-7.Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
REF 53J Med Chem. 2009 Jul 9;52(13):4063-7.Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273.
REF 54Bioorg Med Chem Lett. 2009 May 15;19(10):2642-5. Epub 2009 Apr 5.Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
REF 55The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
REF 56Eur J Med Chem. 2010 Jun;45(6):2396-404. Epub 2010 Feb 12.Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
REF 57Bioorg Med Chem. 2008 Oct 15;16(20):9101-5. Epub 2008 Sep 13.In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
REF 58J Med Chem. 2005 Jul 28;48(15):4834-41.Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
REF 59Bioorg Med Chem. 2010 Aug 1;18(15):5498-503. Epub 2010 Jun 22.Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
REF 60Bioorg Med Chem. 2009 Jul 15;17(14):4894-9. Epub 2009 Jun 9.Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
REF 61Bioorg Med Chem Lett. 2005 Feb 15;15(4):963-9.Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?.
REF 62Bioorg Med Chem Lett. 2008 Aug 15;18(16):4624-7. Epub 2008 Jul 10.Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.
REF 63Bioorg Med Chem. 2008 Aug 1;16(15):7424-8. Epub 2008 Jun 13.Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.
REF 64J Med Chem. 2008 Mar 27;51(6):1945-53. Epub 2008 Feb 29.Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
REF 65J Med Chem. 2009 Feb 12;52(3):646-54.Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
REF 66J Med Chem. 2004 Oct 7;47(21):5224-9.Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library.
REF 67Bioorg Med Chem Lett. 2010 Nov 1;20(21):6208-12. Epub 2010 Aug 26.Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of |A- but not of |A-, |?- and |?-carbonic anhydrases.
REF 68Eur J Med Chem. 2010 Nov;45(11):4769-73. Epub 2010 Jul 24.Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide.
REF 69Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
REF 70Bioorg Med Chem. 2010 Jun 15;18(12):4468-74. Epub 2010 May 28.A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.
REF 71J Med Chem. 1999 Jul 15;42(14):2641-50.Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?.
REF 72Bioorg Med Chem Lett. 2008 Jul 15;18(14):3938-41. Epub 2008 Jun 12.Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?.
REF 73Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
REF 74Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9.Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.
REF 75Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6.Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
REF 76Nature of the inhibition of carbonic anhydrase by acetazolamide and benzthiazide. J Pharmacol Exp Ther. 1961 Mar;131:271-4.
REF 77Diuretic activity of a dihydro-analog of benzthiazide; (3-benzylthiomethyl-6-chloro-7-sulfamyl-3,4 dihydro-1,2,4 benzothiadiazine, 1,1-dioxide). Chemotherapia (Basel). 1962;4:405-12.
REF 78Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. Epub 2010 Feb 6.Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
REF 79Understanding the Dual Inhibition of COX-2 and Carbonic Anhydrase-II by Celecoxib and CG100649 Using Density Functional Theory Calculations and other Molecular Modelling Approaches. Protein Pept Lett. 2015;22(10):903-12.
REF 80Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats. Clin Sci (Lond). 2000 Apr;98(4):481-8.
REF 81Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8. Epub 2010 Oct 25.7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range.
REF 82Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6. Epub 2008 Jul 5.Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.
REF 83Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int. 1996 Nov;50(5):1476-82.
REF 84J Med Chem. 2009 Oct 8;52(19):5990-8.Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.
REF 85J Med Chem. 2006 Dec 28;49(26):7683-96.2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
REF 86Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50.
REF 87Bioorg Med Chem Lett. 2005 Mar 15;15(6):1683-6.Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates.
REF 88J Med Chem. 2009 Dec 10;52(23):7528-36.Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.
REF 89Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
REF 90Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity. Bioorg Med Chem. 2010 Jul 15;18(14):5081-9. doi: 10.1016/j.bmc.2010.05.072. Epub 2010 Jun 2.
REF 91Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5. Epub 2008 Nov 1.Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
REF 92Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5. Epub 2010 Apr 28.Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV.
REF 93Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents. J Enzyme Inhib. 1998 Jul;13(4):267-84.
REF 94J Med Chem. 2006 Nov 2;49(22):6539-48.A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
REF 95J Med Chem. 2010 Aug 12;53(15):5511-22.Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
REF 96Bioorg Med Chem. 2009 Apr 1;17(7):2654-7. Epub 2009 Mar 5.Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates.
REF 97Eur J Med Chem. 2010 Mar;45(3):1225-9. Epub 2009 Dec 5.Synthesis and investigation of inhibition effect of fluorinated sulfonamide derivatives on carbonic anhydrase.
REF 98Bioorg Med Chem Lett. 2009 Apr 1;19(7):1855-7. Epub 2009 Feb 26.Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
REF 99Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
REF 100J Med Chem. 2005 Mar 24;48(6):1941-7.Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
REF 101Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101.Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
REF 102Sulfenamido-sulfonamides as inhibitors of carbonic anhydrase isozymes I, II and IV. J Enzyme Inhib. 1997 Aug;12(3):175-90.
REF 103Bioorg Med Chem Lett. 2005 Sep 1;15(17):3821-7.Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.